Subtype
Bladder Neoplasm
CI-CAN-00001978Explore in graph →
Non-malignant390 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001978Explore in graph →
Clinical trials
1,701 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02443844 | Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression | unknown | Phase 4 | 40 | Diskapi Teaching and Research HospitalOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT02007005 | Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer | completed | Phase 1 / Phase 2 | 37 | Abnoba GmbhINDUSTRY | 2 | May 6, 2015 |
| clinicaltrials |
| NCT02422277 | Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomy | unknown | Phase 2 | 60 | Mansoura UniversityOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT00019435 | LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00785694 | Recurrence of Bladder Cancer After Transurethral Resection With Hexvix | withdrawn | Phase 4 | 0 | GE HealthcareINDUSTRY | 1 | Apr 24, 2015 | clinicaltrials |
| NCT02186925 | A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. | unknown | — | 1,000 | Meir Medical CenterOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT00949455 | A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium(LaMB) | unknown | Phase 2 / Phase 3 | 204 | Queen Mary University of LondonOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT02254915 | SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I(SHTC-EUROPE-1) | withdrawn | Phase 3 | 0 | Medical Enterprises Europe B.V.INDUSTRY | 0 | Apr 1, 2015 | clinicaltrials |
| NCT00536588 | A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816) | completed | Phase 1 | 17 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 27, 2015 | clinicaltrials |
| NCT00933374 | Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma(RAD001) | terminated | Phase 2 | 28 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Mar 18, 2015 | clinicaltrials |
| NCT00753415 | A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | completed | Phase 1 | 37 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 17, 2015 | clinicaltrials |
| NCT00918008 | A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer | terminated | — | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT01498172 | BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients | completed | Phase 1 | 23 | Patrice JichlinskiOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01581723 | Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor | unknown | Phase 3 | 150 | Chinese University of Hong KongOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT02345473 | Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy(CirCanCell) | completed | — | 59 | Azienda Ospedaliero-Universitaria Consorziale Policlinico di BariOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT02345499 | Open Versus Laparoscopic Radical Cystectomy(OvsL) | unknown | Phase 2 | 80 | Azienda Ospedaliero-Universitaria Consorziale Policlinico di BariOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT00136175 | Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder | completed | Phase 2 | 68 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 21, 2015 | clinicaltrials |
| NCT00072137 | Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy | terminated | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT02139371 | Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | completed | Early Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Dec 12, 2014 | clinicaltrials |
| NCT01087697 | Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit | completed | Phase 1 | 8 | TengionINDUSTRY | 1 | Dec 10, 2014 | clinicaltrials |
| NCT00393796 | Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma | terminated | Phase 2 | 54 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 13, 2014 | clinicaltrials |
| NCT02228473 | Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort | unknown | N/A | 76 | Seoul National University HospitalOTHER | 1 | Oct 28, 2014 | clinicaltrials |
| NCT00407485 | VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium | completed | Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2014 | clinicaltrials |
| NCT00384891 | Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer | terminated | Phase 3 | 190 | Medical Enterprises Europe B.V.INDUSTRY | 4 | Oct 7, 2014 | clinicaltrials |
| NCT00544609 | Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent(SOGUG-07-01) | completed | Phase 1 | 10 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT02096224 | Sevoflurane Versus Desflurane for Catheter-related Bladder Discomfort | completed | N/A | 108 | Seoul National University HospitalOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT02238886 | Radical Cystectomy, Nutrition and Convalescence | completed | N/A | 36 | Rigshospitalet, DenmarkOTHER | 1 | Sep 12, 2014 | clinicaltrials |
| NCT01284205 | First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC | withdrawn | Phase 3 | 0 | Bioniche Life Sciences Inc.INDUSTRY | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00634621 | Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer | completed | — | 283 | GE HealthcareINDUSTRY | 1 | Aug 25, 2014 | clinicaltrials |
| NCT02174185 | Compare the Quality of Life Between Patients With Conduit Diversions or Orthotopic Neobladders | unknown | — | 300 | Huazhong University of Science and TechnologyOTHER | 1 | Aug 4, 2014 | clinicaltrials |
| NCT00213655 | URO-BCG-4 : Bladder Tumors Immunotherapy | completed | — | 146 | University Hospital, RouenOTHER | 1 | Jul 31, 2014 | clinicaltrials |
| NCT01688414 | Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer | withdrawn | N/A | 0 | Stanford UniversityOTHER | 0 | Jul 29, 2014 | clinicaltrials |
| NCT00313599 | Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | University of California, San FranciscoOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00623064 | Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer | completed | Phase 1 | 18 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 1, 2014 | clinicaltrials |
| NCT00112905 | Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium | terminated | Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
| NCT00471536 | Pazopanib in Treating Patients With Metastatic Urothelial Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 3 | May 30, 2014 | clinicaltrials |
| NCT01711112 | Salvage Docetaxel for Pretreated Urothelial Cancer | completed | Phase 2 | 31 | Samsung Medical CenterOTHER | 1 | May 15, 2014 | clinicaltrials |
| NCT01240824 | Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer(BCG) | completed | Early Phase 1 | 3 | University of VirginiaOTHER | 1 | Apr 14, 2014 | clinicaltrials |
| NCT02113501 | Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study | completed | — | 200 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Apr 14, 2014 | clinicaltrials |
| NCT01395225 | Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer | completed | — | 32 | University of British ColumbiaOTHER | 1 | Mar 13, 2014 | clinicaltrials |
| NCT02074189 | Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer | unknown | Phase 3 | 200 | Southwest Hospital, ChinaOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT02074241 | Molecular Markers of Chemosensitivity for Bladder Cancer | unknown | — | 200 | Southwest Hospital, ChinaOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT01304173 | Retrospective Chart Review of Valstar | completed | — | 113 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00802633 | Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device? | terminated | N/A | 80 | Vanderbilt UniversityOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT01639521 | Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer | withdrawn | Phase 2 | 0 | University of Southern CaliforniaOTHER | 0 | Jan 29, 2014 | clinicaltrials |
| NCT00553124 | Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer | unknown | Phase 3 | 3,400 | University Hospital BirminghamOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00553215 | Quality of Life in Patients With Bladder Cancer | unknown | — | 2,700 | University of BirminghamOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00553345 | Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer | unknown | Phase 3 | 515 | University of BirminghamOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00553566 | Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer | unknown | — | 1,600 | University of BirminghamOTHER | 1 | Jan 10, 2014 | clinicaltrials |
Data updated 23 days agoSource updated May 14, 2015source: clinicaltrials